Tue, January 14, 2025
Mon, January 13, 2025

Lilly Asks Biden Administration to Pause Drug-Price Negotiations

  Copy link into your clipboard //politics-government.news-articles.net/content/ .. nistration-to-pause-drug-price-negotiations.html
  Print publication without navigation Published in Politics and Government on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Drugmaker Eli Lilly & Co. has asked the US government to pause its forward march with drug-price negotiations, potentially thwarting the Biden administration's plans to release a new list of drug targets before leaving office next week.
Eli Lilly has requested that the Biden administration pause its drug price negotiation program, arguing that the process lacks transparency and could hinder innovation in the pharmaceutical industry. The company expressed concerns that the negotiations, part of the Inflation Reduction Act, might not adequately consider the value of new medicines or the costs associated with their development. Lilly's CEO, David Ricks, emphasized the need for a more open dialogue with the government to ensure that the pricing strategy supports continued research and development while making drugs affordable. This request comes amidst ongoing debates about how best to balance drug affordability with the incentives for pharmaceutical innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/politics/government/lilly-asks-biden-administration-to-pause-drug-price-negotiations/ar-BB1rnZ74 ]